News
FDA expands recall on blood pressure medicine
The Food and Drug Administration (FDA) has announced an expansion to the voluntary recall on
The Food and Drug Administration (FDA) has announced an expansion to the voluntary recall on Losartan Potassium Tablets.
The recall has expanded to include an additional 36 lots.
The FDA says Torrent is recalling the product because the levels of N-MethyInitrosobutyric acid (NMBA) are above the acceptable daily intake levels.
Losartan is used to treat hypertension and for nephropathy in Type 2 diabetic patients.
A complete list of the recall can be found below.
Stories
Videos
| News Apps | |||
 |
 |
||
